Stay updated on Maplirpacept in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Maplirpacept in Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Record history shows multiple updates to core content, including study status, contacts/locations, and study description, across numerous versions. The latest version indicates termination of the study by Pfizer with no safety concerns reported.
    Difference
    0.1%
    Check dated 2025-11-02T01:01:24.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Updated operating status notice and a new software version (v3.2.0) replacing the old v3.1.0.
    Difference
    9%
    Check dated 2025-10-04T12:28:50.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Update: Revision from v3.0.2 to v3.1.0. This is a versioning change with no other substantive content alterations.
    Difference
    0.2%
    Check dated 2025-09-27T08:08:36.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.5%
    Check dated 2025-09-13T01:45:51.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.5%
    Check dated 2025-09-05T19:54:35.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    48%
    Check dated 2025-08-29T18:40:56.000Z thumbnail image

Stay in the know with updates to Maplirpacept in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.